Scientific Publications by FDA Staff
J Radioanal Nucl Che 2013 Apr;296(1):5-22
The urgent requirement for new radioanalytical certified reference materials for nuclear safeguards, forensics, and consequence management
Inn KGW, Johnson CM, Oldham W, Jerome S, Tandon L, Schaaff T, Jones R, Mackney D, MacKill P, Palmer B, Smith D, LaMont S, Griggs J
A multi-agency workshop was held from 25 to 27 August 2009, at the National Institute of Standards and Technology (NIST), to identify and prioritize the development of radioanalytical Certified Reference Materials (CRMs, generally provided by National Metrology Institutes; Standard Reference Materials, a CRM issued by NIST) for field and laboratory nuclear measurement methods to be used to assess the consequences of a domestic or international nuclear event. Without these CRMs, policy makers concerned with detecting proliferation and trafficking of nuclear materials, attribution and retribution following a nuclear event, and public health consequences of a nuclear event would have difficulty making decisions based on analytical data that would stand up to scientific, public, and judicial scrutiny. The workshop concentrated on three areas: post-incident Improvised Nuclear Device (IND) nuclear forensics, safeguard materials characterization, and consequence management for an IND or a Radiological Dispersion Device detonation scenario. The workshop identified specific CRM requirements to fulfill the needs for these three measurement communities. Of highest priority are: (1) isotope dilution mass spectrometry standards, specifically 233U, 236gNp, 244Pu, and 243Am, used for quantitative analysis of the respective elements that are in critically short supply and in urgent need of replenishment and certification; (2) CRMs that are urgently needed for post-detonation debris analysis of actinides and fission fragments, and (3) CRMs used for destructive and nondestructive analyses for safeguards measurements, and radioisotopes of interest in environmental matrices.
|Category: Journal Article|
|Includes FDA Authors from Scientific Area(s): Regulatory Affairs|
|Entry Created: 2013-05-08|